WARD Home Pilot

WARD Home Pilot

Study design
Prospective study/cohort
Sample size
80 participants
Principal Investigator

Vibeke Eriksen, MD, Ph.d.

Study sites

Bispebjerg Hospital and the patient’s own homes

Inclusion criteria

Adult patients (≥ 18 years) admitted with an acute medical disease and who are scheduled for discharge to their own homes within five days from inclusion.

Study procedures

Included patients are monitored with WARD equipment during the last part of hospitalization and the first days after discahrge. Monitoring will last for a maximum of eight days.

Outcome

Minutes during the measurement period with complete data from the LifeTouch device.

Trial registration
NCT05223504